Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation.
OBJECTIVE
To demonstrate a radiation dose response and to determine the dosimetric and chemotherapeutic factors that influence the incidence of late renal toxicity following total body irradiation (TBI).


METHODS
A comprehensive retrospective review was performed of articles reporting late renal toxicity, along with renal dose, fractionation, dose rate, chemotherapy regimens, and potential nephrotoxic agents. In the final analysis, 12 articles (n = 1,108 patients), consisting of 24 distinct TBI/chemotherapy conditioning regimens were included. Regimens were divided into three subgroups: adults (age > or =18 years), children (age <18 years), and mixed population (both adults and children). Multivariate logistic regression was performed to identify dosimetric and chemotherapeutic factors significantly associated with late renal complications.


RESULTS
Individual analysis was performed on each population subgroup. For the purely adult population, the only significant variable was total dose. For the mixed population, the significant variables included total dose, dose rate, and the use of fludarabine. For the pediatric population, only the use of cyclosporin or teniposide was significant; no dose response was noted. A logistic model was generated with the exclusion of the pediatric population because of its lack of dose response. This model yielded the following significant variables: total dose, dose rate, and number of fractions.


CONCLUSIONS
A dose response for renal damage after TBI was identified. Fractionation and low dose rates are factors to consider when delivering TBI to patients undergoing bone marrow transplantation. Drug therapy also has a major impact on kidney function and can modify the dose-response function.
Cheng
Jonathan C
JC
Department of Radiation Oncology, City of Hope Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA.
Schultheiss
Timothy E
TE
Wong
Jeffrey Y C
JY
D000328:Adult; D000367:Age Factors; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D002648:Child; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000528:radiation effects*; D011832:Radiation Injuries / Q000209:etiology*; D011879:Radiotherapy Dosage; D012044:Regression Analysis; D012062:Relative Biological Effectiveness; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods; D014916:Whole-Body Irradiation / Q000009:adverse effects*
D000970:Antineoplastic Agents